These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 33043484)
1. Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis. Ionescu F; Jaiyesimi I; Petrescu I; Lawler PR; Castillo E; Munoz-Maldonado Y; Imam Z; Narasimhan M; Abbas AE; Konde A; Nair GB Eur J Haematol; 2021 Feb; 106(2):165-174. PubMed ID: 33043484 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19. Hoogenboom WS; Lu JQ; Musheyev B; Borg L; Janowicz R; Pamlayne S; Hou W; Duong TQ PLoS One; 2022; 17(1):e0262811. PubMed ID: 35045130 [TBL] [Abstract][Full Text] [Related]
3. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study. Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Moonla C; Sosothikul D; Chiasakul T; Rojnuckarin P; Uaprasert N Clin Appl Thromb Hemost; 2021; 27():10760296211008999. PubMed ID: 33874753 [TBL] [Abstract][Full Text] [Related]
5. Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis. Parisi R; Costanzo S; Di Castelnuovo A; de Gaetano G; Donati MB; Iacoviello L Semin Thromb Hemost; 2021 Jun; 47(4):372-391. PubMed ID: 33851386 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort. Ionescu F; Grasso-Knight G; Castillo E; Naeem E; Petrescu I; Imam Z; Patel VK; Narasimhan M; Nair GB TH Open; 2020 Jul; 4(3):e263-e270. PubMed ID: 32995704 [TBL] [Abstract][Full Text] [Related]
8. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Al-Samkari H; Gupta S; Leaf RK; Wang W; Rosovsky RP; Brenner SK; Hayek SS; Berlin H; Kapoor R; Shaefi S; Melamed ML; Sutherland A; Radbel J; Green A; Garibaldi BT; Srivastava A; Leonberg-Yoo A; Shehata AM; Flythe JE; Rashidi A; Goyal N; Chan L; Mathews KS; Hedayati SS; Dy R; Toth-Manikowski SM; Zhang J; Mallappallil M; Redfern RE; Bansal AD; Short SAP; Vangel MG; Admon AJ; Semler MW; Bauer KA; Hernán MA; Leaf DE; Ann Intern Med; 2021 May; 174(5):622-632. PubMed ID: 33493012 [TBL] [Abstract][Full Text] [Related]
9. Regular Use of VKA Prior to COVID-19 Associated with Lower 7-Day Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Cohort Study. Ménager P; Brière O; Gautier J; Riou J; Sacco G; Brangier A; Annweiler C; Geria-Covid Study Group OBOT Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374341 [TBL] [Abstract][Full Text] [Related]
10. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. Rentsch CT; Beckman JA; Tomlinson L; Gellad WF; Alcorn C; Kidwai-Khan F; Skanderson M; Brittain E; King JT; Ho YL; Eden S; Kundu S; Lann MF; Greevy RA; Ho PM; Heidenreich PA; Jacobson DA; Douglas IJ; Tate JP; Evans SJW; Atkins D; Justice AC; Freiberg MS BMJ; 2021 Feb; 372():n311. PubMed ID: 33574135 [TBL] [Abstract][Full Text] [Related]
11. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis. Meizlish ML; Goshua G; Liu Y; Fine R; Amin K; Chang E; DeFilippo N; Keating C; Liu Y; Mankbadi M; McManus D; Wang SY; Price C; Bona RD; Ochoa Chaar CI; Chun HJ; Pine AB; Rinder HM; Siner JM; Neuberg DS; Owusu KA; Lee AI Am J Hematol; 2021 Apr; 96(4):471-479. PubMed ID: 33476420 [TBL] [Abstract][Full Text] [Related]
13. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765 [TBL] [Abstract][Full Text] [Related]
14. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19. Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129 [TBL] [Abstract][Full Text] [Related]
15. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19. Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulation outcomes in hospitalized Covid-19 patients: A systematic review and meta-analysis of case-control and cohort studies. Kamel AM; Sobhy M; Magdy N; Sabry N; Farid S Rev Med Virol; 2021 May; 31(3):e2180. PubMed ID: 33022834 [TBL] [Abstract][Full Text] [Related]